Diverse roles of LPA signaling in the intestinal epithelium

Experimental Cell Research

Volumn 333, Issue 2, 2015, Pages 201-207

  Yun, C Chris ^a,b   Kumar, Ajay ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Colon cancer; Inflammation; Intestine; Lysophosphatidic acid

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID;

ANGIOGENESIS; CANCER GROWTH; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; ELECTROLYTE TRANSPORT; FOCAL ADHESION; HUMAN; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL COMMUNICATION; COLORECTAL TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL COMMUNICATION; COLORECTAL NEOPLASMS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LYSOPHOSPHOLIPIDS; SIGNAL TRANSDUCTION;

EID: 84927910265     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.11.013     Document Type: Review

References (53)

1. Blikslager A.T., Moeser A.J., Gookin J.L., Jones S.L., Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol. Rev. 2007, 87:545-564.
2. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 2009, 49:123-150.
3. Aoki J. Mechanisms of lysophosphatidic acid production. Semin. Cell Dev. Biol. 2004, 15:477-489.
4. Nakane S., Tokumura A., Waku K., Sugiura T. Hen egg yolk and white contain high amounts of lysophosphatidic acids, growth factor-like lipids: distinct molecular species compositions. Lipids 2001, 36:413-419.
5. Tanaka T., Kassai A., Ohmoto M., Morito K., Kashiwada Y., Takaishi Y., Urikura M., Morishige J., Satouchi K., Tokumura A. Quantification of phosphatidic acid in foodstuffs using a thin-layer-chromatography-imaging technique. J. Agric. Food Chem. 2012, 60:4156-4161.
6. Tanaka T., Horiuchi G., Matsuoka M., Hirano K., Tokumura A., Koike T., Satouchi K. Formation of lysophosphatidic acid, a wound-healing lipid, during digestion of cabbage leaves. Biosci. Biotechnol. Biochem. 2009, 73:1293-1300.
7. Navab M., Hough G., Buga G.M., Su F., Wagner A.C., Meriwether D., Chattopadhyay A., Gao F., Grijalva V., Danciger J.S., Van Lenten B.J., Org E., Lusis A.J., Pan C., Anantharamaiah G.M., Farias-Eisner R., Smyth S.S., Reddy S.T., Fogelman A.M. Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid. J. Lipid Res. 2013, 54:3403-3418.
8. Yung Y.C., Stoddard N.C., Chun J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J. Lipid Res. 2014, 55:1192-1214.
9. + exchanger 3 and fluid absorption via LPA5 and NHERF2. Gastroenterology 2010, 138:649-658.
10. Lee S.-J., Leoni G., Neumann P.-A., Chun J., Nusrat A., Yun C.C. Distinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure. Mol. Cell. Biol. 2013, 33:2016-2028.
11. Yun C.C., Sun H., Wang D., Rusovici R., Castleberry A., Hall R.A., Shim H. LPA2 receptor mediates mitogenic signals in human colon cancer cells. Am. J. Physiol. 2005, 289:C2-C11.
12. Goetzl E.J., Kong Y., Voice J.K. Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. J. Immunol. 2000, 164:4996-4999.
13. Kotarsky K., Boketoft A., Bristulf J., Nilsson N.E., Norberg A., Hansson S., Owman C., Sillard R., Leeb-Lundberg L.M., Olde B. Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J. Pharmacol. Exp. Ther. 2006, 318:619-628.
14. Lundequist A., Boyce J.A. LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1β release. PLoS ONE 2011, 6:e18192.
15. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170.
16. Stracke M.L., Krutzsch H.C., Unsworth E.J., Arestad A., Cioce V., Schiffmann E., Liotta L.A. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 1992, 267:2524-2529.
17. Kazama S., Kitayama J., Aoki J., Mori K., Nagawa H. Immunohistochemical detection of autotaxin (ATX)/lysophospholipase D (lysoPLD) in submucosal invasive colorectal cancer. J. Gastrointest. Cancer 2011, 42:204-211.
18. Khurana S., Tomar A., George S.P., Wang Y., Siddiqui M.R., Guo H., Tigyi G., Mathew S. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia. Exp. Cell Res. 2008, 314:530-542.
19. Prestwich G.D., Gajewiak J., Zhang H., Xu X., Yang G., Serban M. Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer. Biochim. Biophys. Acta 1781, 2008:588-594.
20. Goetzl E.J., Dolezalova H., Kong Y., Hu Y.-L., Jaffe R.B., Kalli K.R., Conover C.A. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 1999, 59:5370-5375.
21. Shida D., Watanabe T., Aoki J., Hama K., Kitayama J., Sonoda H., Kishi Y., Yamaguchi H., Sasaki S., Sako A., Konishi T., Arai H., Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab. Investig. 2004, 84:1352-1362.
22. Yang M., Zhong W.W., Srivastava N., Slavin A., Yang J., Hoey T., An S. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway. Proc. Natl. Acad. Sci. USA 2005, 102:6027-6032.
23. Zhang H., Bialkowska A., Rusovici R., Chanchevalap S., Shim H., Katz J.P., Yang V.W., Yun C.C. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Kruppel-like factor 5. J. Biol. Chem. 2007, 282:15541-15549.
24. Sun B., Nishihira J., Yoshiki T., Kondo M., Sato Y., Sasaki F., Todo S. Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the rho-dependent pathway. Clin. Cancer Res. 2005, 11:1050-1058.
25. Yang D., Yang W., Zhang Q., Hu Y., Bao L., Damirin A. Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2. Oncol. Lett. 2013, 5:1048-1052.
26. Shida D., Kitayama J., Yamaguchi H., Okaji Y., Tsuno N.H., Watanabe T., Takuwa Y., Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003, 63:1706-1711.
27. Shin K.J., Kim Y.L., Lee S., Kim D.K., Ahn C., Chung J., Seong J.Y., Hwang J.I. Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells. J. Cancer Res. Clin. Oncol. 2009, 135:45-52.
28. Shida D., Kitayama J., Yamaguchi H., Hama K., Aoki J., Arai H., Yamashita H., Mori K., Sako A., Konishi T., Watanabe T., Sakai T., Suzuki R., Ohta H., Takuwa Y., Nagawa H. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells. Exp. Cell Res. 2004, 301:168-178.
29. 5 receptor. PLoS ONE 2011, 6:e29260.
30. Ghaleb A.M., Nandan M.O., Chanchevalap S., Dalton W.B., Hisamuddin I.M., Yang V.W. Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 2005, 15:92-96.
31. Min) mutation in the intestine. Cancer Res. 2009, 69:4125-4133.
32. Murph M.M., Hurst-Kennedy J., Newton V., Brindley D.N., Radhakrishna H. Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells. Mol. Cancer Res. 2007, 5:1201-1211.
33. Lee S.-J., No Y.R., Dang D.T., Dang L.H., Yang V.W., Shim H., Yun C.C. Regulation of hypoxia-inducible Factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5. J. Biol. Chem. 2013, 288:25244-25253.
34. Deng W., E S., Tsukahara R., Valentine W.J., Durgam G., Gududuru V., Balazs L., Manickam V., Arsura M., Vanmiddlesworth L., Johnson L.R., Parrill A.L., Miller D.D., Tigyi G. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology 2007, 132:1834-1851.
35. Rusovici R., Ghaleb A., Shim H., Yang V.W., Yun C.C. Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of bad. Biochim. Biophys. Acta 1770, 2007:1194-1203.
36. Lee S.-J., Ritter S.L., Zhang H., Shim H., Hall R.A., Yun C.C. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells. Gastroenterology 2011, 140:923-934.
37. Lin S., Lee S.J., Shim H., Chun J., Yun C.C. The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G1128-G1138.
38. Lin S., Wang D., Iyer S., Ghaleb A.M., Shim H., Yang V.W., Chun J., Yun C.C. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology 2009, 136:1711-1720.
39. Tatsuta M., Iishi H., Baba M., Uedo N., Ishihara R., Higashino K., Mukai M., Ishiguro S. Induction by lysophosphatidic acid of peritoneal and pleural metastases of intestinal cancers induced by azoxymethane in Wistar rats. Cancer Lett. 2005, 219:137-145.
40. Sturm A., Sudermann T., Schulte K.M., Goebell H., Dignass A.U. Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterology 1999, 117:368-377.
41. Hines O.J., Ryder N., Chu J., McFadden D. Lysophosphatidic acid stimulates intestinal restitution via cytoskeletal activation and remodeling. J. Surg. Res. 2000, 92:23-28.
42. Jiang X., Jacamo R., Zhukova E., Sinnett-Smith J., Rozengurt E. RNA interference reveals a differential role of FAK and Pyk2 in cell migration, leading edge formation and increase in focal adhesions induced by LPA in intestinal epithelial cells. J. Cell. Physiol. 2006, 207:816-828.
43. Adachi M., Horiuchi G., Ikematsu N., Tanaka T., Terao J., Satouchi K., Tokumura A. Intragastrically administered lysophosphatidic acids protect against gastric ulcer in rats under water-immersion restraint stress. Dig. Dis. Sci. 2011, 56:2252-2261.
44. Ohta H., Sato K., Murata N., Damirin A., Malchinkhuu E., Kon J., Kimura T., Tobo M., Yamazaki Y., Watanabe T., Yagi M., Sato M., Suzuki R., Murooka H., Sakai T., Nishitoba T., Im D.-S., Nochi H., Tamoto K., Tomura H., Okajima F. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol. 2003, 64:994-1005.
45. Kanda H., Newton R., Klein R., Morita Y., Gunn M.D., Rosen S.D. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat. Immunol. 2008, 9:415-423.
46. Hozumi H., Hokari R., Kurihara C., Narimatsu K., Sato H., Sato S., Ueda T., Higashiyama M., Okada Y., Watanabe C., Komoto S., Tomita K., Kawaguchi A., Nagao S., Miura S. Involvement of autotaxin/lysophospholipase D expression in intestinal vessels in aggravation of intestinal damage through lymphocyte migration. Lab. Invest. 2013, 93:508-519.
47. Shida D., Kitayama J., Yamaguchi H., Yamashita H., Mori K., Watanabe T., Nagawa H. Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells. World J. Gastroenterol. 2005, 11:5638-5643.
48. + exchanger NHE3. J. Biomed. Biotechnol. 2010, (2010):238080.
49. Field M. Intestinal ion transport and the pathophysiology of diarrhea. J. Clin. Invest. 2003, 111:931-943.
50. Li C., Dandridge K.S., Di A., Marrs K.L., Harris E.L., Roy K., Jackson J.S., Makarova N.V., Fujiwara Y., Farrar P.L., Nelson D.J., Tigyi G.J., Naren A.P. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J. Exp. Med. 2005, 202:975-986.
51. Singh A.K., Riederer B., Krabbenhoft A., Rausch B., Bonhagen J., Lehmann U., de Jonge H.R., Donowitz M., Yun C., Weinman E.J., Kocher O., Hogema B.M., Seidler U. Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice. J. Clin. Invest. 2009, 119:540-550.
52. +) exchanger 3 via apical epidermal growth factor receptor in intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 2011, 301:C1008-1016.
53. Kiss G.N., Fells J.I., Gupte R., Lee S.-C., Liu J., Nusser N., Lim K.G., Ray R.M., Lin F.-T., Parrill A.L., Sumegi B., Miller D.D., Tigyi G.J. Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions. Mol. Pharmacol. 2012, 82:1162-1173.